Table 4.
Univariate and multivariate analyses of nodal failure for all enrolled LNs.
Risk Factors | Nodal Failure Rate | Univariate Analysis (χ2 Test) |
Multivariate Analysis (Logistic Test) |
|
---|---|---|---|---|
p Value | HR (95%CI) | p Value | ||
Dpre (cm) | ||||
≥1.15 vs. <1.15 | 12.2% vs. 4.8% | 0.016 | — | — |
Vpre (cm3) | ||||
≥2.85 vs. <2.85 | 14.8% vs. 3.4% | <0.001 | — | — |
D20F (cm) | ||||
≥0.95 vs. <0.95 | 20.1% vs. 1.8% | <0.001 | 6.855 (1.402–33.518) | 0.017 |
V20F (cm3) | ||||
≥3.45 vs. <3.45 | 27.2% vs. 4.2% | <0.001 | — | — |
ΔD20F | ||||
<0.245 vs. ≥0.245 | 24.1% vs. 3.1% | <0.001 | — | — |
ΔV20F | ||||
<0.435 vs. ≥0.435 | 23.9% vs. 3.1% | <0.001 | 3.069 (1.027–9.170) | 0.045 |
Histology | ||||
Non-SCC vs. SCC | 20.0% vs. 8.3% | 0.034 | — | — |
Radiation dose (Gy) | ||||
<60 vs. ≥60 | 18.4% vs. 6.4% | 0.001 | — | — |
Cycles of CT | ||||
<4 vs. ≥4 | 22.8% vs. 5.5% | <0.001 | 3.635 (1.441–9.166) | 0.006 |
Distribution of LNs | ||||
PALNM vs. PLNM | 16.4% vs. 7.8% | 0.035 | — | — |